Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
0.3%
1w
2.9%
1m
2.3%
3m
15.5%
6m
60.8%
1y
88.2%
all
16.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,066 0.3%
884
1,224
Company Overview
Sales
330 Cr
Growth: -8.0%
Profit after Tax
95.5 Cr
Growth: 24.8%
Small Cap
2,631 Cr
P/E: 27.5x
Industry P/E: 28.3x
Fundamentals
Sales (Cr) ₹ 330
Growth -8.0%
EBITDA 19.2%
P/S 8.0x
Dividend 1.1%
P/E 27.5x
Book Value ₹ 343
PEG Ratio -3.4x
ROE 11.8%
P/B 3.1x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (4 Indices)
Investors (7)
iepf
abdul.ha...
total